News
Press Releases & Media
Latest updates from Carvolix and our portfolio companies.
Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026
Press Release
Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026
July 06, 2026
Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme
Press Release
Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme
June 24, 2026
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software
Press Release
Carvolix announces positive 3-years clinical results for Kalios™, the only adjustable mitral ring
June 16, 2026
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software
Press Release
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT
AI Software
May 4, 2026
Carvolix is born and funded
Press Release
Carvolix is born and funded
- Affluent Medical officially becomes CARVOLIX
- Completion of the acquisitions of CARANX MEDICAL and ARTEDRONE
- 10m€ first tranche of financing completed
February 2026
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
Press Release
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
December 2025